Using a quantitative real-time PCR analysis, we confirmed the effects of pretreatment with fingolimod-phosphate on the mRNA expression of claudin-5, VCAM-1 and NFκB in the BMECs after MS sera exposure. Here, CLDN5 is linked to myeloid sarcoma.